Business Combination (Details) - USD ($) |
Oct. 07, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 16, 2020 |
|---|---|---|---|---|
| Business Combination | ||||
| Preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | |
| Pharmagesic | ||||
| Business Combination | ||||
| Percentage of shares acquired | 100.00% | |||
| Maximum percentage issued | 19.99% | |||
| Preferred stock, par value (in dollars per share) | $ 0.0001 | |||
| Number of shares of common issuable for each preferred share | 10,000 | |||
| Transaction costs | $ 4,900,000 | |||
| Total Consideration Paid | $ 71,265,727 | |||
| Pharmagesic | Common stock | ||||
| Business Combination | ||||
| Number of shares issued | 211,383 | |||
| Pharmagesic | Series A Non-Voting Convertible Preferred Stock | ||||
| Business Combination | ||||
| Number of shares issued | 2,108.3854 |
| X | ||||||||||
- Definition Percentage that voting equity interests issued comprise of the outstanding shares existing before time of issuance. No definition available.
|
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of common shares issuable upon conversion for each share of preferred stock to be converted. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|